Novo Nordisk (NVO) Stock Surges as FDA Approves Oral Wegovy Weight-Loss Pill

TLDR FDA approved Novo Nordisk’s oral Wegovy pill on Monday, causing shares to rally 9.5% in after-hours trading The 25 mg oral semaglutide tablet is the first oral GLP-1 medication approved for weight management in the United States Trial data showed patients lost 16.6% of body weight over 64 weeks versus 2.7% on placebo Launch [...]

The post Novo Nordisk (NVO) Stock Surges as FDA Approves Oral Wegovy Weight-Loss Pill appeared first on Blockonomi.